Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
48
BBIO
BridgeBio Pharma
Last Price:
$33.79
Seasonality Move:
-4.32%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.45 | Buy |
20-day SMA: | 29.52 | Buy |
50-day SMA: | 27.49 | Buy |
200-day SMA: | 26.72 | Buy |
8-day EMA: | 32.71 | Buy |
20-day EMA: | 30.5 | Buy |
50-day EMA: | 28.38 | Buy |
200-day EMA: | 27.2 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.91 | Buy |
Relative Strength Index (14 RSI): | 68.27 | Buy |
Chaikin Money Flow: | -2512401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.44 - 31.96) | Buy |
Bollinger Bands (100): | (24.1 - 29.32) | Buy |
BridgeBio Pharma Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.79 while BBIO 8-day simple moving average is 32.45, which is a Buy signal.
-
The stock price of BBIO is 33.79 while BridgeBio Pharma 20-day SMA is 29.52, which makes it a Buy.
-
BridgeBio Pharma 50-day simple moving average is 27.49 while BBIO share price is 33.79, making it a Buy technically.
-
BBIO stock price is 33.79 and BridgeBio Pharma 200-day simple moving average is 26.72, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
48
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a SellThe current BridgeBio Pharma [BBIO] share price is $33.79. The Score for BBIO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
6.4B
Price in USD:
33.79
Share Volume:
2.7M
BridgeBio Pharma 52-Week Range
52-Week High:
41.04
52-Week Low:
21.62
Sell
48
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 33.79 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.79 while BBIO 8-day exponential moving average is 32.71, which is a Buy signal.
-
The stock price of BBIO is 33.79 while BridgeBio Pharma 20-day EMA is 30.50, which makes it a Buy.
-
BridgeBio Pharma 50-day exponential moving average is 28.38 while BBIO share price is 33.79, making it a Buy technically.
-
BBIO stock price is 33.79 and BridgeBio Pharma 200-day simple moving average is 27.20, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.16 per share, and an increase next year of $0.70 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 1.91, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 68.27, which suggest BridgeBio Pharma is overbought
-
The Bollinger Bands (25) for BridgeBio Pharma is (26.44 - 31.96), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (24.1 - 29.32), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.